Status:
UNKNOWN
Effect of Fetuin A in Hemodialysis Patients
Lead Sponsor:
University of Shizuoka
Collaborating Sponsors:
Maruyama Memorial General Hospital
Conditions:
Hemodialysis
Malnutrition
Eligibility:
All Genders
Up to 70 years
Brief Summary
The purpose of this study is to examined the effect of fetuin A on atherosclerosis and prognosis in hemodialysis patients.
Detailed Description
Fetuin A is known to be a potent inhibitor of ectopic calcification in plasma, and the concentration of fetuin A is closely associated with protein nutritional status. The purpose of this study is to ...
Eligibility Criteria
Inclusion
- Hemodialysis for at least 6 months
Exclusion
- Disabled patients
Key Trial Info
Start Date :
March 1 2001
Trial Type :
OBSERVATIONAL
End Date :
March 1 2006
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00309426
Start Date
March 1 2001
End Date
March 1 2006
Last Update
May 22 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maruyama Hospital
Hamamatsu, Shizuoka, Japan, 430-0001